University of Washington
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).
University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.
University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.
Top-decile sponsor footprint
University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,048 total, page 8 of 21
Improving Implementation of Lung Cancer Screening in Diverse Populations II
NCT05265897
Mobile Mental Health Apps for Suicide Prevention
NCT04536935
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer
NCT04383743
Collaborating to Heal Addiction and Mental Health in Primary Care
NCT04600414
Hepatitis C Pharmacy-based Strategy for Injectors
NCT04698629
Postoperative Hip Bracing After Hip Arthroscopy
NCT04599296
Training LHDs to Disseminate Evidence-Based Interventions to Small Worksites
NCT03930420
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
NCT04568980
Early Detection of GEnetic Risk (EDGE)
NCT04746794
Biofeedback-VR for Treatment of Chronic Migraine
NCT05720819
A Guide to Conservative Care
NCT04919941
A Hybrid Type 2 Trial of Trauma-Focused Cognitive Behavioral Therapy and a Pragmatic Individual-Level Implementation Strategy
NCT04451161
Socially Isolated Older Adults Living With Dementia
NCT03666624
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
NCT04561453
Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot
NCT04265807
Cultural Adaptation of a Behavioral Intervention for Latino Caregivers
NCT04633408
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer
NCT03649841
Implementing mHealth for Schizophrenia in Community Mental Health Settings
NCT04147897
Living in Full Even With Pain Study
NCT03916276
Doppler Flow Wires in Cerebral Angiography
NCT03145701
Sequenced Treatment Effectiveness for Posttraumatic Stress
NCT04597190
Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities
NCT04220229
Waking Hypnosis in the Treatment of MS-related Fatigue
NCT04429789
Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms
NCT04196010
Sleep Innovations for Preschoolers With Arthritis (SIPA): Developing and Pilot Testing of a Self-Management Intervention
NCT04354337
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer
NCT03999515
Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic
NCT04360850
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
NCT04281784
Treatment for COVID-19 in High-Risk Adult Outpatients
NCT04354428
A Smartphone Intervention for Relational and Mental Well Being
NCT04629755
Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)
NCT04328961
Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma
NCT04156828
Telehealth Pain Self-Management for Employed Adults
NCT04248725
Triglyceride Effects on Blood Flow in the Human Brain
NCT05218018
Cooking for Health
NCT03699709
Life Enhancing Alcohol-management Program
NCT04302740
Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children
NCT04260048
Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose
NCT04623086
Acupuncture for Headache Post-Traumatic Brain Injury: A Feasibility Study
NCT04216173
Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT04155840
Water-friendly Virtual Reality and Brief Thermal Pain
NCT04245475
Participatory Design of Electronic Health Record Tools for Problem Solving Therapy
NCT03516513
The College, Alcohol and Peers Study (CAPS)
NCT03890484
Alcohol & Mobile Phone Study to Reduce High-risk Alcohol Use and Consequences
NCT04213846
Evaluation of mHealth for Serious Mental Illness
NCT04068467
Glenohumeral Cortisone Injection
NCT04216017
Test-and-treat for Influenza in Homeless Shelters
NCT04141917
Sleep Shared-Management Intervention for Children With Juvenile Idiopathic Arthritis
NCT04066205
Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle
NCT04141930
Coping and Adjusting to Living With Multiple Sclerosis
NCT04300816
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 127 |
| Phase 2 | 193 |
| Phase 3 | 39 |
| Phase 4 | 65 |
What is open in the University of Washington pipeline
156 recruiting of 1,048 indexed (15% open); 720 completed (69%).
Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).
Top condition: Depression (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Washington: open-pipeline peers nationwide
Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,048 trials (± recruiting share)
- University of Wisconsin, Madison · 1,039 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Arizona State University · 15% recruiting · 187 trials
- Georgetown University · 15% recruiting · 227 trials
Related
What to do with this University of Washington page
1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.
- 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.